Life (Jan 2024)

Artificial Intelligence in Heart Failure: Friend or Foe?

  • Angeliki Bourazana,
  • Andrew Xanthopoulos,
  • Alexandros Briasoulis,
  • Dimitrios Magouliotis,
  • Kyriakos Spiliopoulos,
  • Thanos Athanasiou,
  • George Vassilopoulos,
  • John Skoularigis,
  • Filippos Triposkiadis

DOI
https://doi.org/10.3390/life14010145
Journal volume & issue
Vol. 14, no. 1
p. 145

Abstract

Read online

In recent times, there have been notable changes in cardiovascular medicine, propelled by the swift advancements in artificial intelligence (AI). The present work provides an overview of the current applications and challenges of AI in the field of heart failure. It emphasizes the “garbage in, garbage out” issue, where AI systems can produce inaccurate results with skewed data. The discussion covers issues in heart failure diagnostic algorithms, particularly discrepancies between existing models. Concerns about the reliance on the left ventricular ejection fraction (LVEF) for classification and treatment are highlighted, showcasing differences in current scientific perceptions. This review also delves into challenges in implementing AI, including variable considerations and biases in training data. It underscores the limitations of current AI models in real-world scenarios and the difficulty in interpreting their predictions, contributing to limited physician trust in AI-based models. The overarching suggestion is that AI can be a valuable tool in clinicians’ hands for treating heart failure patients, as far as existing medical inaccuracies have been addressed before integrating AI into these frameworks.

Keywords